Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder
about
Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3Focusing on diffuse (interstitial) lung disease: a rapidly evolving fieldTGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT)Functional and phenotypical comparison of myofibroblasts derived from biopsies and bronchoalveolar lavage in mild asthma and sclerodermaThe Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host DiseaseMYCL1, FHIT, SPARC, p16(INK4) and TP53 genes associated to lung cancer in idiopathic pulmonary fibrosisLoss of RAGE in pulmonary fibrosis: molecular relations to functional changes in pulmonary cell typesNitric oxide mediates bleomycin-induced angiogenesis and pulmonary fibrosis via regulation of VEGFEpithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis.Molecular and functional properties of lung SP cells.The effect of TGF-β1 and Smad7 gene transfer on the phenotypic changes of rat alveolar epithelial cells.Clinical and radiological features of idiopathic interstitial pneumonias (IIPs): a pictorial reviewMatrix metalloproteinase-19 is a key regulator of lung fibrosis in mice and humansReactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis.Impact of serum SP-A and SP-D levels on comparison and prognosis of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.PPAR-γ ligands repress TGFβ-induced myofibroblast differentiation by targeting the PI3K/Akt pathway: implications for therapy of fibrosis.Following the path of CCL2 from prostaglandins to periostin in lung fibrosisHigh throughput determination of TGFβ1/SMAD3 targets in A549 lung epithelial cellsInhibition of Wnt/beta-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis.A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model.Comprehensive microRNA analysis in bleomycin-induced pulmonary fibrosis identifies multiple sites of molecular regulation.Comparison of epithelial differentiation and immune regulatory properties of mesenchymal stromal cells derived from human lung and bone marrowTroglitazone attenuates TGF-β1-induced EMT in alveolar epithelial cells via a PPARγ-independent mechanism.Portal fibroblasts regulate the proliferation of bile duct epithelia via expression of NTPDase2.Regional differences in susceptibiity of bronchial epithelium to mesenchymal transition and inhibition by the macrolide antibiotic azithromycin.Inflammatory leukocyte phenotypes correlate with disease progression in idiopathic pulmonary fibrosis.Novel therapeutic approaches for pulmonary fibrosis.Blocking follistatin-like 1 attenuates bleomycin-induced pulmonary fibrosis in mice.The in vivo fibrotic role of FIZZ1 in pulmonary fibrosisIdiopathic pulmonary fibrosis: update on genetic discoveries.Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44.Severity of lung injury in cyclooxygenase-2-deficient mice is dependent on reduced prostaglandin E(2) production.Fibroblast growth factor 2 is required for epithelial recovery, but not for pulmonary fibrosis, in response to bleomycinRole of endoplasmic reticulum stress in epithelial-mesenchymal transition of alveolar epithelial cells: effects of misfolded surfactant protein.Genome sequencing of idiopathic pulmonary fibrosis in conjunction with a medical school human anatomy course.Tgf-beta downregulation of distinct chloride channels in cystic fibrosis-affected epithelia.Delayed stress fiber formation mediates pulmonary myofibroblast differentiation in response to TGF-β.The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factorSPARC oppositely regulates inflammation and fibrosis in bleomycin-induced lung damage.Normal Human Lung Epithelial Cells Inhibit Transforming Growth Factor-β Induced Myofibroblast Differentiation via Prostaglandin E2
P2860
Q24624887-608FB3CF-90F6-48FE-8AAF-3660F9881D05Q24807129-54FC007E-6680-4DAE-951B-C112D2E84747Q24813751-4D0074F6-2C3E-4796-A964-05AA236F7905Q25255751-8100DFCE-3513-4D4D-866D-FF0BC2A8BEC0Q28076264-E7F67462-78CE-4339-8E5E-3E0B5A913989Q28217248-E6A35C17-9B09-4C84-B0D4-C9EA69E4F737Q28276929-F0912857-39FF-451E-B62F-1F7929D6FB3AQ28389679-31CDA4A9-29CE-46BD-88BF-F0ADD3172E9EQ30484036-3CB2310F-8472-4B7F-8707-96D4F69648A6Q33265316-7DB9E32A-893A-435F-82B6-AE13F06B930BQ33282713-F511900C-D766-4D70-93D9-682589200606Q33671533-7D607090-4293-4378-9070-855F4859E0C7Q33745690-6E5DC418-9ADC-4495-B13C-5C8067AE8865Q33754678-516BDCC8-6AAF-42CD-959F-42E6D879C5A6Q33783426-C4F8A6B1-F012-41A6-BB3E-CA64EBE38508Q33799182-2BEA569E-F3B9-43E2-8404-0DD50FB3DE01Q33799756-D1D14ABE-E921-4157-89F9-AED7400CB431Q33916249-74CCBF3B-EFC2-4E0A-9CF6-5BC282262842Q34069594-DBD61F1E-4634-403A-8FF1-FBCD85E4C3D9Q34116805-7119987B-F5A6-40D5-8780-DF3556BCDEA9Q34160776-87D87D6D-C4E1-4B27-9145-5E0D57F771DAQ34261568-16768C2B-3707-4EF6-B2BA-AFAF1F4FAD61Q34321160-45C0A6AE-2CD0-453B-99C5-8601F10ED12BQ34407473-F2CB86C1-EA55-4173-BF4A-FC1A259DAC64Q34533624-9BFB7D64-9D85-4AB4-995E-938F615C07BAQ34857355-0D6C9CB7-5706-45AB-8615-868096B47343Q34903224-5E702FE8-FFBF-45F3-945D-211191D2F5C3Q35064880-B1FCEAD4-419E-4E96-B64F-E94BC63C3AFEQ35091707-41F1B985-E2B6-4707-ACA5-8164B9564EA1Q35092480-CBADC4F7-778D-4EF8-B944-555963AE9CCFQ35102315-45291389-A38B-4C9C-BB7C-B955C5C00909Q35103340-661CDB61-D3A2-441D-B7D5-97AD1834505AQ35207699-5043CDE6-EB3A-4C57-B30F-E78B26DCFC40Q35219868-B5AF4027-26B5-42FB-A7FC-5ACF1A364CDFQ35239965-24CBF85E-8AE3-43FB-9D12-50D67B3282CEQ35287714-DB790047-F91A-45D7-9AD0-704CF7221AC8Q35543607-8FC975C3-0385-4D09-9FCC-2B6E53622677Q35654823-6EDD4F09-D33F-446D-B944-3842C47072B3Q35679638-DA932E78-0BD0-4856-943F-1C8D650B2CC1Q35738996-BBA77DEE-E662-4A85-A866-BFC5A84B4226
P2860
Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder
description
2002 nî lūn-bûn
@nan
2002 թուականին հրատարակուած գիտական յօդուած
@hyw
2002 թվականին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder
@ast
Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder
@en
Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder
@nl
type
label
Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder
@ast
Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder
@en
Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder
@nl
prefLabel
Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder
@ast
Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder
@en
Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder
@nl
P2860
P921
P3181
P356
P1433
P1476
Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder
@en
P2093
Annie Pardo
Moisés Selman
P2860
P2888
P3181
P356
10.1186/RR175
P407
P577
2001-10-11T00:00:00Z
2002-01-01T00:00:00Z
P5875
P6179
1019406667